Literature DB >> 28814521

HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels.

Lise Chauveau1,2, Daniel Aaron Donahue3,2, Blandine Monel3,2, Francoise Porrot3,2, Timothée Bruel3,2, Lea Richard3,2, Nicoletta Casartelli3,2, Olivier Schwartz1,2,4.   

Abstract

HIV-1 poorly infects monocyte-derived dendritic cells (MDDCs). This is in large part due to SAMHD1, which restricts viral reverse transcription. Pseudotyping HIV-1 with vesicular stomatitis virus G protein (VSV-G) strongly enhances infection, suggesting that earlier steps of viral replication, including fusion, are also inefficient in MDDCs. The site of HIV-1 fusion remains controversial and may depend on the cell type, with reports indicating that it occurs at the plasma membrane or, conversely, in an endocytic compartment. Here, we examined the pathways of HIV-1 entry in MDDCs. Using a combination of temperature shift and fusion inhibitors, we show that HIV-1 fusion mainly occurs at the cell surface. We then asked whether surface levels or intracellular localization of CD4 modulates HIV-1 entry. Increasing CD4 levels strongly enhanced fusion and infection with various HIV-1 isolates, including reference and transmitted/founder strains, but not with BaL, which uses low CD4 levels for entry. Overexpressing coreceptors did not facilitate viral infection. To further study the localization of fusion events, we generated CD4 mutants carrying heterologous cytoplasmic tails (LAMP1 or Toll-like receptor 7 [TLR7]) to redirect the molecule to intracellular compartments. The intracellular CD4 mutants did not facilitate HIV-1 fusion and replication in MDDCs. Fusion of an HIV-2 isolate with MDDCs was also enhanced by increasing surface CD4 levels. Our results demonstrate that MDDCs are inefficiently infected by various HIV-1 and HIV-2 strains, in part because of low CD4 levels. In these cells, viral fusion occurs mainly at the surface, and probably not after internalization.IMPORTANCE Dendritic cells (DCs) are professional antigen-presenting cells inducing innate and adaptive immune responses. DCs express the HIV receptor CD4 and are potential target cells for HIV. There is debate about the sensitivity of DCs to productive HIV-1 and HIV-2 infection. The fusion step of the viral replication cycle is inefficient in DCs, and the underlying mechanisms are poorly characterized. We show that increasing the levels of CD4 at the plasma membrane allows more HIV fusion and productive infection in DCs. We further demonstrate that HIV fusion occurs mainly at the cell surface and not in an intracellular compartment. Our results help us understand why DCs are poorly sensitive to HIV infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  dendritic cells; human immunodeficiency virus; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28814521      PMCID: PMC5640872          DOI: 10.1128/JVI.01248-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood.

Authors:  Angela Granelli-Piperno; Irina Shimeliovich; Maggi Pack; Christine Trumpfheller; Ralph M Steinman
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 2.  The role of endosomes in innate and adaptive immunity.

Authors:  Paul A Gleeson
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

3.  Mapping the human DC lineage through the integration of high-dimensional techniques.

Authors:  Peter See; Charles-Antoine Dutertre; Jinmiao Chen; Patrick Günther; Naomi McGovern; Sergio Erdal Irac; Merry Gunawan; Marc Beyer; Kristian Händler; Kaibo Duan; Hermi Rizal Bin Sumatoh; Nicolas Ruffin; Mabel Jouve; Ester Gea-Mallorquí; Raoul C M Hennekam; Tony Lim; Chan Chung Yip; Ming Wen; Benoit Malleret; Ivy Low; Nurhidaya Binte Shadan; Charlene Foong Shu Fen; Alicia Tay; Josephine Lum; Francesca Zolezzi; Anis Larbi; Michael Poidinger; Jerry K Y Chan; Qingfeng Chen; Laurent Rénia; Muzlifah Haniffa; Philippe Benaroch; Andreas Schlitzer; Joachim L Schultze; Evan W Newell; Florent Ginhoux
Journal:  Science       Date:  2017-05-04       Impact factor: 47.728

4.  Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.

Authors:  Cinzia Nobile; Caroline Petit; Arnaud Moris; Katharina Skrabal; Jean-Pierre Abastado; Fabrizio Mammano; Olivier Schwartz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1.

Authors:  Heather Donaghy; Brian Gazzard; Frances Gotch; Steven Patterson
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

6.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

7.  Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry.

Authors:  Alicia M Janas; Chunsheng Dong; Jian-Hua Wang; Li Wu
Journal:  Virology       Date:  2008-03-10       Impact factor: 3.616

8.  Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors.

Authors:  A Granelli-Piperno; B Moser; M Pope; D Chen; Y Wei; F Isdell; U O'Doherty; W Paxton; R Koup; S Mojsov; N Bhardwaj; I Clark-Lewis; M Baggiolini; R M Steinman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

9.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Actin Dynamics Regulates Dendritic Cell-Mediated Transfer of HIV-1 to T Cells.

Authors:  Mickaël M Ménager; Dan R Littman
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

View more
  9 in total

Review 1.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

2.  Mucosal Immunity and HIV Acquisition in Women.

Authors:  Laura Moreno de Lara; Ragav S Parthasarathy; Marta Rodriguez-Garcia
Journal:  Curr Opin Physiol       Date:  2020-08-18

3.  Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells.

Authors:  Robert Lodge; Julian C Gilmore; Jérémy A Ferreira Barbosa; Félix Lombard-Vadnais; Éric A Cohen
Journal:  Viruses       Date:  2017-12-30       Impact factor: 5.048

Review 4.  HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.

Authors:  Jérémy Dufloo; Timothée Bruel; Olivier Schwartz
Journal:  Retrovirology       Date:  2018-07-28       Impact factor: 4.602

5.  HIV-1 Fusion with CD4+ T cells Is Promoted by Proteins Involved in Endocytosis and Intracellular Membrane Trafficking.

Authors:  Mariana Marin; Yulia Kushnareva; Caleb S Mason; Sumit K Chanda; Gregory B Melikyan
Journal:  Viruses       Date:  2019-01-25       Impact factor: 5.048

Review 6.  Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1.

Authors:  Bernadien M Nijmeijer; Teunis B H Geijtenbeek
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 7.  Nanoparticle-Based Immunoengineered Approaches for Combating HIV.

Authors:  Allan Bowen; Elizabeth E Sweeney; Rohan Fernandes
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 8.  Dendritic Cells, the Double Agent in the War Against HIV-1.

Authors:  Alba Martín-Moreno; Mª Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

9.  Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity.

Authors:  Devin DeCotes; Sarah Baron; Jonathon Hoffman; Meghan Garrett; Hakimuddin Sojar; Mark D Hicar
Journal:  Arch Virol       Date:  2022-07-24       Impact factor: 2.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.